Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02069002
Other study ID # TSR113076
Secondary ID TTL338270202
Status Completed
Phase N/A
First received
Last updated
Start date February 2014
Est. completion date July 30, 2018

Study information

Verified date February 2017
Source Finnish Institute of Occupational Health
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the current study is to compare the effictiveness of three different psychosocial therapies for treating functional disorders caused by indoor air problems.


Description:

Indoor air -related respiratory and other multiple organ symptoms are common in work environments in Finland. Symptoms effect on well-being and quality of life and may lead to impaired social and cognitive functioning and decreased work ability. All indoor air -related conditions are not explained by underlying physical factors and remain medically unexplained. Functional disorders are conditions where patients complain of multiple medically unexplained physical symptoms or physical problems don´t correlate with symptom severity. Indoor air -related symptoms and functional disorders are strongly associated to each other but there are no well-established diagnostic criteria for the condition . So far, there is no available treatment program to the indoor air -related symptoms to offer in primary or occupational health care services in Finland.

In randomized controlled trials, cognitive behavioral treatment has shown to be effective for patients suffering from functional disorders. In addition, a relaxation technique entitled as applied relaxation (Tuomisto & al, 1996) have shown to been shown to been effective to treat different kind of functional problems.

There are no published trials on treatment for individuals of indoor air related symptomatology. The present study is designed as a pragmatic trial to investigate the effect of three different treatment programs as compared to treatment as usual (TAU) for indoor air- related problems in order to improve the (1) work capacity and (2) well-being. A secondary aim of the study is to identify psychological factors affecting the patients' response to the treatment.

The patients are recruited from occupational health care services to establish and to evaluate the efficacy and usability of the treatment procedures. Participants will first undergo baseline assessment including medical examination of the respiratory symptoms. Then they are randomized to one of the study groups: TAU or one of the intervention groups. All study patients receive TAU at occupational health care services for their medical problems during the study. Patients randomized to the study groups receive also the intervention with TAU.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date July 30, 2018
Est. primary completion date July 29, 2018
Accepts healthy volunteers No
Gender All
Age group 25 Years to 58 Years
Eligibility Inclusion Criteria:

1. Self-assessed work ability not more than 7 (on a scale 0-10, compared to lifetime best) (removed, see below)

2. Employed minimum three (3) or more years

3. Symptoms related to work environment indoor air (non-industrial workplaces)

4. Respiratory symptoms related to indoor air

5. And symptoms involve more than one other organ system

6. Symptoms onset maximum three years before the study

7. Symptoms are recurrent

8. Symptoms appear more than one (1) environment or continue after repairs environmental exposure(s)

9. No single widely acceptable test of organ system function can explain the symptoms (symptoms are medically unexplained)

10. Minimum of one sick leave due to indoor air symptoms during the preceding half year

11. Fluent Finnish (write/read/speak) (due the interventions)

Exclusion Criteria:

1. six (6) months or more sick leave sick leaves due to indoor air symptoms during the preceding two years and currently unable to work

2. Planned changes in the work (for example retirement, study free period, pregnancy etc.) during the study

3. An acute, untreated medical disorder or illnesses:

1. Somatic disease that explains the symptoms

2. An acute, untreated mental disorder (depression, bipolar disorder, psychotic disorders, obsessive-compulsive disorder, eating disorders, personality disorders)

3. Abuse of narcotics or alcohol or (non-prescribed) medicine

4. Developmental disorders

4. Psychotherapy (current or has ended preceding two years)

5. No inform consent

6. Other: Patient refusal; not actively participating working life (retired or unemployed)

Based on a steering group´s advice and agreement (10.10.2014), inclusion criteria (Self-assessed work ability not more than 7, on a scale 0-10, compared to lifetime best) was removed. Recruitment continues without this question as an inclusion criteria.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive-Behavioral Therapy (CBT)

Applied relaxation group therapy

Information session (psychoeducation)


Locations

Country Name City State
Finland Finnish Institute of Occupational Health (Finland) Helsinki Uusimaa

Sponsors (8)

Lead Sponsor Collaborator
Finnish Institute of Occupational Health City of Helsinki, Finnish Work Environment Fund, Mehiläinen Oy healthcare service company (Finland), Terveystalo healthcare service company (Finland), The Occupational Health Centre of the city of Espoo, The Occupational Health Centre of the city of Vantaa, The Social Insurance Institution of Finland

Country where clinical trial is conducted

Finland, 

References & Publications (3)

Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med. 2001 Jul;33(5):328-36. Review. — View Citation

Tuomi T Ilmarinen J, Jahkola A, Katajarinne l, Tulkki A (1998) Work ability index. Finnish Institute of Occupational Health, Helsinki.

Tuomisto MT, Lappalainen R, Tuomisto T, Timonen T. [Applied relaxation in psychiatry and behavioral therapy]. Duodecim. 1996;112(11):960-7. Review. Finnish. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Working Alliance Inventory (WAI) Self-report measure that assesses three key aspects of the therapeutic alliance: (a) agreement on the tasks of therapy, (b) agreement on the goals of therapy and (c) development of an affective bond; for therapists and the patient of the individual cognitive-behavior therapy after the first, fifth and the last session of the CBT
Other Sense of coherence Group (SOC-G-20) For the group therapy patients to evaluate the groups therapeutic alliance. after the first, fourth and the last session of the grouptherapy
Other Satisfaction of the treatment Questionnaire for the intervention groups patients to evaluate the satisfaction of the treatment and its efficacy. 3, 6 and 12 months from the baseline
Primary 15D - instrument The health-related quality of life (HRQoL) instrument (Sintonen, 2001) baseline, 3, 6 and 12 months from the baseline
Secondary • Generalized Anxiety Disorder (GAD-7) Self-report measure that assesses anxiety symptoms baseline, 3, 6 and 12 months from the baseline
Secondary Insomnia Severity Index (ISI) Self-report measure that assesses insomnia severity baseline, 3, 6 and 12 months from the baseline
Secondary The Symptom checkList-90 (SCL-90) Self-report measure that assesses general psychological and somatic symptoms and severity baseline, 6 and 12 months from the baseline
Secondary The Patient Health Questionnaire (PHQ-9) Self-report measure that assesses depressive symptoms baseline, 3, 6 and 12 months from the baseline
Secondary Visual Analogue Scale (VAS) Self-report measure that assesses respiratory symptom severity baseline, 3, 6 and 12 months from the baseline
Secondary The Acceptance and Action Questionnaire-2 (AAQ-2) Self-report measure focuses on experiential avoidance and psychological inflexibility baseline, 3, 6 and 12 months from the baseline
Secondary Illness Worry Scale (IWS) Self-report measure that focuses on illness worries and attitudes towards illness baseline, 3, 6 and 12 months from the baseline
Secondary Penn State Worry Questionnaire (PSWQ) Self-report measure that focuses on mourning and continuous worrying toughs baseline, 3, 6 and 12 months from the baseline
Secondary Need for Recovery (NRF) Self-report measure that focuses on time needed on the recovery after work day baseline, 3, 6 and 12 months from the baseline
Secondary Strategy and Attribution Questionnaire (SAQ) Self-report measure focuses on personal attribute strategies. baseline, 6 and 12 months from the baseline
Secondary Self-assessed work ability Self-assessed work ability (on a scale 0-10) (Tuomi & al. 1998) baseline, 3, 6 and 12 months from the baseline
See also
  Status Clinical Trial Phase
Completed NCT01536288 - Can Rhodiola Crenulata Intake Improve Oxygen Saturation and Decrease the Incidence of Acute Mountain Sickness Phase 2
Not yet recruiting NCT06447974 - The Barts Charity Children's Environmental Health Clinic N/A